Position in BIO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$309,171
+$29,585 QoQ
Shares Held
1,053
+5.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#237
of 397 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 10%
Shared 0%
None 90%
Common Shares in BIO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $192,998,899 across 51 Medical Devices names. BIO ranks #25 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
509,302 | $46,214,063 | |
| 2 | STE |
STERIS plc
|
209,519 | $44,118,415 | |
| 3 | SYK |
Stryker Corp
|
138,667 | $43,657,918 | |
| 4 | MDT |
Medtronic plc
|
258,603 | $20,230,512 | |
| 5 | EW |
Edwards Lifesciences Corp
|
60,926 | $5,511,365 | |
| 6 | BSX |
Boston Scientific Corp
|
123,736 | $5,281,052 | |
| 7 | DXCM |
Dexcom Inc
|
47,517 | $3,200,269 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
47,861 | $3,063,582 |
All Filings in BIO
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $309,171 | 1,053 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $279,586 | 1,003 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $270,267 | 892 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $244,500 | 872 | Shares | Sole | 2025-11-19 | |
| 2025-03-31 | $1,876,386 | 7,704 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,882,362 | 5,730 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $256,288 | 766 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $270,925 | 992 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $583,482 | 1,687 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $556,662 | 1,724 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $583,198 | 1,627 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $707,058 | 1,865 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $537,460 | 1,122 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $406,613 | 967 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $322,449 | 773 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $386,595 | 781 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $412,284 | 732 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $451,075 | 597 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $511,721 | 686 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $416,211 | 646 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $342,702 | 600 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $45,469 | 78 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $41,236 | 80 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $13,544 | 30 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||